Drew Young has been appointed senior vice president of Neurology and Immunology at EMD Serono, Inc. Mr. Young will be responsible for leading the strategic direction of the U.S. Neurology and Immunology franchise, including future products.
He has more than 20 years of experience leading global and U.S. marketing and sales efforts at pharma and biopharma companies. He joins the company from Biogen Idec, where he was the marketing lead of the interferon franchise for the multiple sclerosis (MS) business.
"Drew is a proven commercial leader and a key addition to EMD Serono's strengthened leadership team," said Gary Zieziula, chief commercial officer of EMD Serono. "His knowledge and experience in MS and proven track record of commercial success, will add to our organization's continued drive to innovate on behalf of the MS patient community."